Browse Category

Stock Market 24 September 2025

Acadia Healthcare’s Wild 2025 Ride: Activist Investor Shake-Up, Stock Surge & Mental Health Market Frenzy

Acadia Healthcare’s Wild 2025 Ride: Activist Investor Shake-Up, Stock Surge & Mental Health Market Frenzy

Acadia Healthcare’s stock has been on a rollercoaster. As of September 24, 2025, ACHC traded around the mid-$20s per share after a sudden spike in the wake of activist investor news reuters.com. This rally – nearly a 9% jump in one afternoon – offered relief to shareholders who had endured a prolonged slide. Before the late-September rebound, Acadia’s stock was down roughly 41% year-to-date in 2025 investing.com and hovering near multi-year lows. The stock’s swoon followed a series of setbacks that eroded investor confidence. In fact, shares had collapsed over 70% from their all-time high in 2022 reuters.com, when Acadia was riding optimism about behavioral health demand. By early September 2025, the stock languished in the low-$20s, reflecting these troubles.
24 September 2025
VNET Group’s AI-Fueled Data Center Boom Sends Stock Soaring – What Investors Need to Know

VNET Group’s AI-Fueled Data Center Boom Sends Stock Soaring – What Investors Need to Know

VNET Group, Inc. has emerged as a key beneficiary of China’s cloud and AI data center boom, translating surging demand into rapid revenue growth and an eye-popping stock rally. Recent wins like the 40MW hyperscale deal reinforce its credibility, and analysts remain largely bullish, citing strong execution and strategic backing from both tech giants and state-linked investors. However, investors should weigh the breakneck expansion against its high leverage and volatile earnings. VNET’s ascent in the Chinese data center arena – powering everything from cloud services to AI training – positions it for further growth, but prudent management of its debt-fueled expansion will be crucial. Overall, VNET offers a compelling play on China’s digital infrastructure expansion, with a growth story that’s capturing Wall Street’s attention as the company stakes out its territory in the era of AI-driven cloud computing.
Cidara Therapeutics (CDTX) Surges on Accelerated Flu Drug Trial – Key Updates for Investors

Cidara Therapeutics (CDTX) Surges on Accelerated Flu Drug Trial – Key Updates for Investors

Cidara’s stock has been on a tear in 2025, delivering triple-digit percentage gains. Year-to-date, CDTX has risen about +173% as of late September investing.com, driven by upbeat trial results and investor enthusiasm for its flu program. The stock recently surged over 20% in one day after the Phase 3 acceleration news, reaching an intraday high of approximately $87.75 on Sept. 24 marketbeat.com marketbeat.com. This is effectively a new 52-week high, far above its 52-week low of ~$10 marketbeat.com. By comparison, Cidara’s market capitalization now stands around $2.0–2.3 billion at these prices marketbeat.com, a remarkable appreciation reflecting heightened expectations for the company.
24 September 2025
Opendoor’s Meteoric Comeback: How Meme Hype and Housing Hopes Fueled a 1600% Stock Surge

Opendoor’s Meteoric Comeback: How Meme Hype and Housing Hopes Fueled a 1600% Stock Surge

Opendoor Technologies has had a whirlwind year in 2025, transforming from a beaten-down afterthought into a retail trader darling. By early July, the San Francisco-based iBuyer’s stock languished below $1 – so low that Opendoor faced Nasdaq delisting for failing to meet the $1 minimum share price. The company even scheduled a shareholder vote to approve a reverse stock split to rescue its listing benzinga.com.
24 September 2025
Gene Therapy Breakthrough: uniQure’s QURE Stock Skyrockets on Huntington’s Triumph

Gene Therapy Breakthrough: uniQure’s QURE Stock Skyrockets on Huntington’s Triumph

uniQure’s stock performance in 2025 has been remarkably strong, capped by the explosive move on Sep. 24 after the Huntington’s data release. Prior to the announcement, QURE was trading in the mid-teens ts2.tech – already up over 100% year-to-date as anticipation for the trial results built. When the pivotal results hit, trading was halted pre-market due to pending news ts2.tech. Once the halt lifted, the stock opened dramatically higher and at one point reached the mid-$40s per share, up nearly 160–200% in a single session pharmaphorum.com. It eventually closed with a gain of around 150%+ on the day investing.com. This massive one-day jump is one of the biotech sector’s biggest of 2025, reflecting how transformational the news was for uniQure’s outlook.
Nasdaq’s 48-Hour Whiplash: AI Mega-Deals, Fed Curveballs & Record Highs

Nasdaq’s 48-Hour Whiplash: AI Mega-Deals, Fed Curveballs & Record Highs

Wall Street began the week in celebration mode – by Monday’s close, the Nasdaq Composite, S&P 500, and Dow had all notched record-high closes, extending a rally fueled by hopes of looser monetary policy and tech sector strength. The Nasdaq ended that session at 22,788.98, its third straight record, as investors piled into big tech nasdaq.com. The spark came from the Federal Reserve’s surprise pivot: on Sept. 17 the Fed delivered its first interest rate cut of the year, a 25 bps trim to 4.00–4.25% nasdaq.com. Hopes for easier borrowing costs – and hints of further cuts likely in 2025 – had injected fresh optimism into equities reuters.com. “The rate cut is expected to add to Wall Street’s recent rally,” noted CFRA strategist Sam Stovall, as lower rates boost the net present value of stocks, especially high-growth tech reuters.com.
Wall Street Roiled: Fed Warning Cools Rally as AI Frenzy Ignites Stocks and Crash Fears

Wall Street Roiled: Fed Warning Cools Rally as AI Frenzy Ignites Stocks and Crash Fears

Wall Street’s rally hit a speed bump as the Federal Reserve signaled it won’t rush to ease policy. On Tuesday, Fed Chair Jerome Powell struck a delicate balance: he noted the central bank must “balance inflation concerns with a weakening job market” when considering future rate moves reuters.com. Importantly for investors, Powell offered no clues on the timing or size of the next interest-rate cut reuters.com. His cautious stance – and his remark that equity valuations are “fairly highly valued” – immediately cooled the market’s exuberance reuters.com. The major indexes, which had all notched record highs in the prior three sessions, pulled back modestly on Tuesday reuters.com.
Riot Platforms (RIOT) Skyrockets as Bitcoin Booms – Latest News, Insights & Forecasts

Riot Platforms (RIOT) Skyrockets as Bitcoin Booms – Latest News, Insights & Forecasts

Riot Platforms’ fortunes are tightly linked to the broader crypto market – and lately, that market has been on fire. Bitcoin prices have skyrocketed in 2025, repeatedly shattering all-time highs. In mid-August, BTC briefly traded above $124,000 coindesk.com coindesk.com, more than triple its price from a year prior. As of late September, Bitcoin hovers around the $110–115k range coindesk.com after a slight consolidation. This crypto bull run – fueled by growing institutional adoption and macroeconomic tailwinds – has lifted all boats in the sector, Riot included. The total value of the crypto market swelled to $4.11 trillion in August stockstotrade.com, indicating massive new inflows into digital assets.
ServiceNow’s AI Revolution: Record Growth, Stock Insights & Bold Moves in 2025

ServiceNow’s AI Revolution: Record Growth, Stock Insights & Bold Moves in 2025

Wall Street Upgrade: ServiceNow grabbed headlines on September 24, 2025 when Morgan Stanley upgraded the stock to Overweight and boosted its price target from $1,040 to $1,250 tipranks.com. The analysts argued that fears of generative AI “disruption” and U.S. federal budget cuts are overdone, obscuring ServiceNow’s strong performance investing.com. In fact, ServiceNow’s platform is seen as benefiting from AI: the company is “well positioned to deliver generative AI capabilities,” creating an attractive risk/reward outlook tipranks.com. Morgan Stanley noted ServiceNow’s “consistent” execution and forecast the company can sustain ~20% subscription revenue growth with over 20% free cash flow gains through FY2027 tipranks.com. The upgrade came despite a sluggish stock in recent months – a sign that analysts expect a rebound as ServiceNow’s AI strategy pays off.
Alibaba Stock Skyrockets on $53B AI Push – Hits 4-Year High, Experts Bullish

Alibaba Stock Skyrockets on $53B AI Push – Hits 4-Year High, Experts Bullish

Alibaba’s stock skyrocketed in late September 2025 after the company dramatically upped its bet on artificial intelligence. On Sept. 24, CEO Eddie Wu took the stage at the annual Apsara Conference and unveiled a bold plan to double down on AI – news that sent investors into a buying frenzy. Alibaba’s Hong Kong shares surged ~9.7% to a four-year high, and its U.S.-listed ADRs leapt a similar 9% in a single day reuters.com reuters.com. The rally pushed BABA near levels not seen since 2021, reflecting a sharp turnaround in market sentiment.
Lithium Americas Stock Skyrockets on U.S. Stake Rumor – EV Boom, Lithium Prices & 2025 Outlook

Lithium Americas Stock Skyrockets on U.S. Stake Rumor – EV Boom, Lithium Prices & 2025 Outlook

Lithium Americas stock went on a roller-coaster in late September 2025. On September 24, shares skyrocketed in pre-market trading after a Reuters report revealed that the U.S. government is considering taking an equity stake in the company Reuters. LAC opened around $5.13 that morning – a dramatic jump from roughly $3 the day before Reuters. In after-hours trading the prior evening, the stock had already leapt as high as $5.54 on the news Reuters. This marked a sharp reversal from September 23, when LAC had slid nearly 7% amid broader market weakness and uncertainty over its funding Morningstar.
uniQure (QURE) Stock Soars on Huntington’s Breakthrough – Key Facts & 2025 Outlook

uniQure (QURE) Stock Soars on Huntington’s Breakthrough – Key Facts & 2025 Outlook

Historic Huntington’s Results: On September 24, 2025, uniQure revealed landmark Phase I/II trial results for its Huntington’s disease gene therapy AMT-130. In patients treated with a one-time injection of AMT-130, disease progression was significantly slowed – by about 75% over three years for those on the high dose reuters.com. Treated patients maintained far more of their motor and cognitive function compared to the expected decline in Huntington’s, which is an invariably progressive and fatal neurodegenerative disorder reuters.com reuters.com. Crucially, there are currently no approved drugs that slow Huntington’s disease, so these results position AMT-130 as potentially the first disease-modifying therapy in this space reuters.com.
MP Materials Stock Skyrockets on Pentagon Deal and Apple Alliance – Rare Earth Boom or Hype?

MP Materials Stock Skyrockets on Pentagon Deal and Apple Alliance – Rare Earth Boom or Hype?

Sources: Official press releases and filings; MP Materials Q2 2025 earnings highlights mining.com reuters.com; Reuters news on record-high stock and DoD/Apple deals reuters.com reuters.com; Mining.com and C&EN coverage of U.S. strategic investments mining.com bosd1.sbcounty.gov; Motley Fool & Zacks investment research analysis nasdaq.com nasdaq.com; MarketBeat/Benzinga analyst rating summaries benzinga.com marketbeat.com; Jefferies conference commentary investing.com investing.com; and recent geopolitical reports on China’s rare earth export policy europarl.europa.eu. All information is up-to-date as of September 24, 2025.
Tawana Resources (TAWNF) 2025 Stock Skyrocket: Lithium Revival or Mirage?

Tawana Resources (TAWNF) 2025 Stock Skyrocket: Lithium Revival or Mirage?

TAWNF’s stock chart for 2025 shows an eye-popping rise, gaining nearly 37-fold in value over the course of the year Marketbeat. On paper, this performance could entice any investor – but it comes with a huge caveat. The ticker symbol “TAWNF” was reassigned to Thai Airways International on OTC markets Marketbeat. In other words, the 2025 rally in TAWNF reflects the resumption of trading and turnaround of Thai Airways – not a sudden comeback of Tawana’s defunct lithium business.
24 September 2025
Palantir’s 2025 Stock Surge: AI Goldmine or Overhyped Bubble?

Palantir’s 2025 Stock Surge: AI Goldmine or Overhyped Bubble?

Palantir’s stock has been on a remarkable tear in 2025. Year-to-date, PLTR shares have more than doubled businessinsider.com, following an astounding +340% gain in 2024 businessinsider.com. This rally made Palantir the single best-performing stock in the S&P 500 for the second year running businessinsider.com. In fact, by mid-2025 Palantir had far outpaced the next-best S&P constituent which was up ~100% businessinsider.com. The stock’s surge has been so dramatic that CEO Alex Karp quipped in his Q2 shareholder letter that the company’s once-vocal critics have been “defanged and bent into a kind of submission” businessinsider.com by Palantir’s recent performance.
Diagnex Inc. (DGNX) Stock Skyrockets in 2025 – An Epic ESG Tech Rally and What’s Next

Diagnex Inc. (DGNX) Stock Skyrockets in 2025 – An Epic ESG Tech Rally and What’s Next

Conclusion: Diagnex Inc. has delivered an eye-popping stock performance in 2025, fueled by its ESG tech vision and bold corporate moves. The company’s sustainability-focused business model and news flow have captured speculative interest, making DGNX a standout story stock of the year. Looking ahead, investors must weigh the tantalizing long-term opportunity – riding the ESG wave and AI integration – against the significant risks of a tiny, unprofitable company attempting explosive growth. With a current Hold consensus and even supporters urging caution until profits emerge finance.yahoo.com marketbeat.com, Diagnex remains a high-risk bet. For those bullish on ESG technology, it could be a ground-floor opportunity in a potential future leader. But for more conservative investors, patience for execution may be prudent before joining this volatile ride.
24 September 2025
Nasdaq’s Wild 48 Hours: Fed Jitters, Tech Tumbles & Surprise Rallies – Sept 23–24 Roundup

Nasdaq’s Wild 48 Hours: Fed Jitters, Tech Tumbles & Surprise Rallies – Sept 23–24 Roundup

Wall Street’s bull run hit turbulence on Tuesday, Sept. 23, after Fed Chair Jerome Powell struck a balanced but cautious tone in his remarks. Speaking six days after the Fed’s first rate cut of 2025, Powell emphasized the “no risk-free path”forward – the central bank must tame inflation without unduly harming the now-weakening job market. Notably, he warned that equity valuations appeared “fairly highly valued,” a signal that the recent surge in stocks may have outpaced fundamentals. This lack of a clear green light on further rate relief rattled investors who had been banking on more easy money. Powell “left the door open for another rate cut” but gave “really no hint of when and how much” it might be, explained Peter Cardillo of Spartan Capital. That ambiguity “began to sell off” the overheated market, which was “ripe for some sort of a pullback,” Cardillo noted.
Asia Markets Rollercoaster: Nikkei Smashes Records as Hang Seng Rebounds – Fed Jitters and Tech Rally Whipsaw Stocks

Asia Markets Rollercoaster: Nikkei Smashes Records as Hang Seng Rebounds – Fed Jitters and Tech Rally Whipsaw Stocks

Japan: Japan’s stock market has been a standout performer. The Nikkei 225 index, propelled by robotics and semiconductor names, broke above its 1980s bubble peak to set a new all-time closing high of 45,630.31on Sept 24 economictimes.indiatimes.com. This marked a recovery from early-session losses that day, as investors piled into AI and data-center stocks like SoftBank and IHI, which led the gains economictimes.indiatimes.com. The broader Topix index also ticked up +0.2% economictimes.indiatimes.com. Analysts noted that recent momentum in Tokyo has been fueled by outsized optimism around tech investments and hopes of corporate reforms cryptorank.io. Even with such exuberance, economic undercurrents are mixed: fresh data showed Japan’s manufacturing activity remained in contraction, underscoring a “challenging situation” as the Bank of Japan balances inflation and growth icmarkets.com. Still, the mood in Tokyo is bullish, with investors “front and center” on Japan after this historic rally cryptorank.io.